Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Labat

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Pharmaceutical and Biomedical Analysis|June 9, 2018
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patientsRafael Reis, Laurence Labat, Marie Allard, et al.
British Journal of Clinical Pharmacology|January 6, 2015
Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activityStéphane Mouly, Vanessa Bloch, Katell Peoc'h, et al.
Pharmaceutics|March 29, 2023
Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic DrugsLéa Darnaud, Clément Delage, Youssef Daali, et al.
Occupational and Environmental Medicine|October 23, 2017
Prenatal exposure to glycol ethers and cryptorchidism and hypospadias: a nested case-control studyCharline Warembourg, Jérémie Botton, Nathalie Lelong, et al.
Molecules (Basel, Switzerland)|March 27, 2025
Cross-Analytical Strategies to Tackle "Medicines in Disguise" Presented as Food Supplements, a New Threat for Human HealthJudith Nzoughet Kouassi, Chouaha Bouzidi, Béatrice Nicolai, et al.
Fundamental & Clinical Pharmacology|November 2, 2017
Population pharmacokinetics of oral baclofen at steady-state in alcoholic-dependent adult patientsLucie Chevillard, Naomi Sabo, Michel Tod, et al.
Drug and Alcohol Dependence|May 31, 2014
KCNH2 polymorphism and methadone dosage interact to enhance QT durationAline Hajj, Kamilia Ksouda, Katell Peoc'h, et al.
Molecular Pharmaceutics|January 12, 2016
Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated BiomarkersCélia Lloret-Linares, Eisuke Miyauchi, Huilong Luo, et al.
Journal of Personalized Medicine|December 29, 2022
Cytochromes P450 and P-Glycoprotein Phenotypic Assessment to Optimize Psychotropic Pharmacotherapy: A Retrospective Analysis of Four Years of Practice in PsychiatryClément Delage, Léa Darnaud, Bruno Etain, et al.
Annals of Intensive Care|November 23, 2020
Management of pharmaceutical and recreational drug poisoningBruno Mégarbane, Mathieu Oberlin, Jean-Claude Alvarez, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Pharmaceutical and Biomedical Analysis|June 9, 2018
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patientsRafael Reis, Laurence Labat, Marie Allard, et al.
British Journal of Clinical Pharmacology|January 6, 2015
Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activityStéphane Mouly, Vanessa Bloch, Katell Peoc'h, et al.
Pharmaceutics|March 29, 2023
Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic DrugsLéa Darnaud, Clément Delage, Youssef Daali, et al.
Occupational and Environmental Medicine|October 23, 2017
Prenatal exposure to glycol ethers and cryptorchidism and hypospadias: a nested case-control studyCharline Warembourg, Jérémie Botton, Nathalie Lelong, et al.
Molecules (Basel, Switzerland)|March 27, 2025
Cross-Analytical Strategies to Tackle "Medicines in Disguise" Presented as Food Supplements, a New Threat for Human HealthJudith Nzoughet Kouassi, Chouaha Bouzidi, Béatrice Nicolai, et al.
Fundamental & Clinical Pharmacology|November 2, 2017
Population pharmacokinetics of oral baclofen at steady-state in alcoholic-dependent adult patientsLucie Chevillard, Naomi Sabo, Michel Tod, et al.
Drug and Alcohol Dependence|May 31, 2014
KCNH2 polymorphism and methadone dosage interact to enhance QT durationAline Hajj, Kamilia Ksouda, Katell Peoc'h, et al.
Molecular Pharmaceutics|January 12, 2016
Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated BiomarkersCélia Lloret-Linares, Eisuke Miyauchi, Huilong Luo, et al.
Journal of Personalized Medicine|December 29, 2022
Cytochromes P450 and P-Glycoprotein Phenotypic Assessment to Optimize Psychotropic Pharmacotherapy: A Retrospective Analysis of Four Years of Practice in PsychiatryClément Delage, Léa Darnaud, Bruno Etain, et al.
Annals of Intensive Care|November 23, 2020
Management of pharmaceutical and recreational drug poisoningBruno Mégarbane, Mathieu Oberlin, Jean-Claude Alvarez, et al.
Pageof 6